<i>In-silico</i> approaches to assessing multiple high-level drug-drug and drug-disease adverse drug effects-Reference-Cited by-同舟云学术

In-silico approaches to assessing multiple high-level drug-drug and drug-disease adverse drug effects

Published:2024-02 Issue: Volume: Page:1-14
ISSN:1742-5255
Container-title:Expert Opinion on Drug Metabolism & Toxicology
language:en
Short-container-title:Expert Opinion on Drug Metabolism & Toxicology

Author:

Xu Xuan¹²³,Riviere Jim E¹²,Raza Shahzad⁴,Millagaha Gedara Nuwan Indika¹³,Ampadi Ramachandran Remya¹²³,Tell Lisa A⁵,Wyckoff Gerald J.¹⁶,Jaberi-Douraki Majid¹²³^ORCID

Affiliation:

1. 1DATA Consortium, www.1DATA.life, Kansas State University Olathe, Olathe, KS, USA

2. Food Animal Residue Avoidance and Databank Program (FARAD), Kansas State University Olathe, Olathe, KS, USA

3. Department of Mathematics, Kansas State University, Manhattan, KS, USA

4. Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA

5. FARAD, Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California-Davis, Davis, CA, USA

6. School of Pharmacy, Division of Pharmacology and Pharmaceutical Sciences, University of Missouri-Kansas, Kansas, USA

Funder

BioNexus KC

Health Research

FARAD program

Kansas State University

Publisher

Informa UK Limited

Subject

Pharmacology,Toxicology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17425255.2023.2299337

Reference86 articles.

1. New approaches to drug safety: a pharmacovigilance tool kit

2. Hsu PL, Robbins H. Complete convergence and the law of large numbers. Proc Natl Acad Sci USA. 1947;33:25–31.

3. Pharmacovigilance [Internet]. [cited 2023 Jul 11]. Available from: https://www.who.int/teams/regulation-prequalification/regulation-and-safety/pharmacovigilance

4. Promoting and Protecting Public Health: How the European Union Pharmacovigilance System Works

5. 21st century pharmacovigilance: efforts, roles, and responsibilities